This inventor holds 1 USPTO granted patent. Top assignee: Roche Innovation Center Copenhagen A/s. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Maj Hedtjarn: Innovator in FGFR3 Modulation
Introduction
Maj Hedtjarn is a notable inventor based in Horsholm, Denmark. She has made significant contributions to the field of medical research, particularly in the modulation of FGFR3 expression. Her work is aimed at addressing medical disorders, such as achondroplasia, through innovative methods.
Latest Patents
Maj Hedtjarn holds a patent for "Compositions and methods for modulation of FGFR3 expression." This patent discloses oligonucleotides that target and hybridize to nucleic acid molecules encoding FGFR3, leading to a reduction in its expression. The reduction of aberrant FGFR3 expression is beneficial for treating certain medical conditions.
Career Highlights
Maj Hedtjarn is currently associated with Roche Innovation Center Copenhagen A/S, where she continues her research and development efforts. Her work at Roche has positioned her as a key player in the field of biotechnology and medical innovation.
Collaborations
Maj collaborates with Soren Ottosen, contributing to the advancement of their shared research goals. Their partnership enhances the innovative potential of their projects.
Conclusion
Maj Hedtjarn's contributions to the modulation of FGFR3 expression highlight her role as an influential inventor in the medical field. Her innovative approaches have the potential to significantly impact the treatment of various medical disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile